Chronic Renal Failure, Cachexia, and Ghrelin

Abstract EN

Protein energy wasting is frequently observed in patients with advanced chronic renal failure and end-stage renal disease.

Anorexia and reduced food intake are critical contributing factors and negatively impact on patients' survival.

Ghrelin is a prophagic peptide produced by the stomach and acting at the hypothalamic level to increase the activity of orexigenic neurons.

In patients with chronic renal disease, plasma levels are increased as a likely effect of reduced renal clearance.

Nevertheless, patients' food intake is significantly reduced, suggesting inflammation-mediated resistance of hypothalamic nuclei to peripheral signals.

A number of forms of evidence show that ghrelin resistance could be overcome by the administration of exogenous ghrelin.

Therefore, ghrelin has been proposed as a potential strategy to improve food intake in chronic renal failure patients with protein energy wasting.

Preliminary data are encouraging although larger prospective clinical trials are needed to confirm the results and to identify those patients who are likely to benefit most from the administration of exogenous ghrelin.